<?xml version="1.0" encoding="ISO-8859-1"?>
<!DOCTYPE ichicsr SYSTEM "http://www.accessdata.fda.gov/xml/icsr-xml-v2.1.dtd">
<ichicsr lang="en">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4149694_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125152633</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>4</safetyreportversion>
		<safetyreportid>PHHY2012AU088166</safetyreportid>
		<primarysourcecountry>AU</primarysourcecountry>
		<occurcountry>AU</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>20130125</transmissiondate>
		<reporttype>2</reporttype>
		<serious>1</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>20121005</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>20130123</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHY2012AU088166</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<linkedreport>
			<linkreportnumb>308257</linkreportnumb>
		</linkedreport>
		<primarysource>
			<reportertitle>Dr.</reportertitle>
			<reportergivename>Krishna Kanth</reportergivename>
			<reporterfamilyname>Manepalli</reporterfamilyname>
			<reporterorganization>West Adelaide CMHS</reporterorganization>
			<reporterstreet>Beaufort Clinic
96 Woodville Rd</reporterstreet>
			<reportercity>Woodville</reportercity>
			<reporterstate>SA</reporterstate>
			<reporterpostcode>5011</reporterpostcode>
			<reportercountry>AU</reportercountry>
			<qualification>1</qualification>
			<observestudytype>3</observestudytype>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>AU</reportercountry>
			<qualification>1</qualification>
			<observestudytype>3</observestudytype>
		</primarysource>
		<primarysource>
			<reportertitle>Mr</reportertitle>
			<reportergivename>Barry</reportergivename>
			<reporterfamilyname>Burr</reporterfamilyname>
			<reporterorganization>West Adelaide CMHS</reporterorganization>
			<reporterstreet>Beaufort Clinic, 96 Woodville Rd</reporterstreet>
			<reportercity>Woodville</reportercity>
			<reporterstate>SA</reporterstate>
			<reporterpostcode>5011</reporterpostcode>
			<reportercountry>AU</reportercountry>
			<qualification>3</qualification>
			<observestudytype>3</observestudytype>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>JM</patientinitial>
			<patientinvestigationnumb>JM20428</patientinvestigationnumb>
			<patientbirthdateformat>102</patientbirthdateformat>
			<patientbirthdate>19850528</patientbirthdate>
			<patientweight>69.8</patientweight>
			<patientheight>174</patientheight>
			<patientsex>1</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Schizophrenia, paranoid type</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Drug abuse</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Tobacco abuse</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Psychotic disorder</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Alcohol abuse</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Bowel infection</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Gastrointestinal infection</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Gastrointestinal infection</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120927</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20121003</reactionenddate>
				<reactionduration>7</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>21</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Diarrhoea gone since about 2 days ago</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Diarrhoea</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Diarrhoea</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120920</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20120929</reactionenddate>
				<reactionduration>10</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>14</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome>1</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Eosinophilia</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Eosinophilia</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Eosinophilia</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120919</reactionstartdate>
				<reactionfirsttime>13</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome>2</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Eosinophilis 4.3</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Eosinophil count increased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Eosinophil count increased</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20121003</reactionstartdate>
				<reactionfirsttime>27</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome>2</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121005</testdate>
				<testname>C-reactive protein</testname>
				<testresult>7.8</testresult>
				<testunit>mg/l</testunit>
				<lowtestrange>6.30</lowtestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121005</testdate>
				<testname>C-reactive protein</testname>
				<testresult>7.8</testresult>
				<testunit>mg/l</testunit>
				<lowtestrange>6.30</lowtestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120924</testdate>
				<testname>Eosinophil count</testname>
				<testresult>0.8</testresult>
				<testunit>10^9/L</testunit>
				<hightestrange>&lt;0.6</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121003</testdate>
				<testname>Eosinophil count</testname>
				<testresult>4.3</testresult>
				<testunit>10^9/L</testunit>
				<hightestrange>&lt;0.6</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121005</testdate>
				<testname>Eosinophil count</testname>
				<testresult>3.0</testresult>
				<testunit>10^9/L</testunit>
				<hightestrange>&lt;0.6</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121009</testdate>
				<testname>Eosinophil count</testname>
				<testresult>0.9</testresult>
				<testunit>10^9/L</testunit>
				<hightestrange>&lt;0.6</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121015</testdate>
				<testname>Eosinophil count</testname>
				<testresult>1.2</testresult>
				<testunit>10^9/L</testunit>
				<hightestrange>&lt;0.6</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>CLOZARIL</medicinalproduct>
				<obtaindrugcountry>AU</obtaindrugcountry>
				<drugauthorizationnumb>19-758</drugauthorizationnumb>
				<drugauthorizationcountry>AU</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>300</drugstructuredosagenumb>
				<drugstructuredosageunit>003</drugstructuredosageunit>
				<drugdosagetext>300 mg</drugdosagetext>
				<drugdosageform>Tablet</drugdosageform>
				<drugadministrationroute>048</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Schizophrenia</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20120907</drugstartdate>
				<drugstartperiod>21</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20121005</drugenddate>
				<drugtreatmentduration>29</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>1</actiondrug>
				<drugrecurreadministration>1</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CLOZAPINE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Diarrhoea</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Diarrhoea</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Eosinophil count increased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Eosinophil count increased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Eosinophilia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Eosinophilia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHY2012AU088166, is an initial PMS report received from a physician via the Clozaril Patient Monitoring Service (CPMS - Patient Registry) on 05 Oct 2012 with follow-up report received from healthcare professional (Clozaril coordinator, nurse) on 10 Oct 2012 with a follow-up report received from the nurse on 29 Oct 2012 with a follow-up report received from the physician on 01 Nov 2012 with follow up report received from physician on 23 Jan 2013. This report refers to 27-year-old male patient (Patient ID: JM20428). The medical history of the patient included paranoid schizophrenia, tetrahydrocannabinol (THC) drug abuse, nicotine abuse and alcohol abuse. The patient received treatment with Clozaril (clozapine) for the treatment of schizophrenia, at a dose of 300 mg from 07 Sep 2012. On 19 Sep 2012 the patient was diagnosed with eosinophilia. On 20 Sep 2012 the patient experienced diarrhoea. On 24 Sep 2012 laboratory data of the patient revealed that eosinophils was 0.8x10^9/L. On 27 Sep 2012 the patient was diagnosed with bowel infection. The issue of raised eosinophils was discussed with haematologist and might be due to a bowel infection which started at approximately the same time as Clozaril. The patient received treatment medication of antibiotics and antidiarrheal. On 03 Oct 2012, laboratory data of the patient revealed that eosinophils count was 4.3x10^9/L. (normal range: &lt;0.6) It was reported that patient had not been on Clozaril for long period. The patient was on Clozaril for 03 weeks and responded very well. On 05 Oct 2012, patient's CRP (C-reactive protein) was reported as 7.8 mg/L. Treatment with Clozaril was discontinued on 05 Oct 2012 (previously reported as 06 Oct 2012). It was also reported the patient would recommence the Clozaril therapy after a three week. On 09 Oct 2012 laboratory data of the patient revealed that eosinophils was 0.9x10^9/L. On 15 Oct 2012 laboratory data of the patient revealed that eosinophils was 1.2x10^9/L. The seriousness of the events bowel infection, eosinophilia, eosinophilis 4.3 and diarrhea was assessed as medically significant and seriousness criteria for other event was not reported. The outcome of the event diarrhoea was completely recovered on 29 Sep 2012, bowel infection was completely recovered on 03 Oct 2012 and for other events was reported as condition improving. The causality of the event eosinophilia was reported as suspected and causality assessment for bowel infection and diarrhea was reported as not suspected with Clozaril and for other event was not reported.

Follow-up report received from healthcare professional (Clozaril coordinator) on 10 Oct 2012: Updated reporter's information, suspect drug information and outcome of the event (eosinophil count increased). Added events (gastrointestinal infection and C-reactive protein increased).

Follow-up report received from the nurse on 29 Oct 2012: Updated information patient's demography (date of birth), event (eosinophilia) and outcome of the event (eosinophilia).

Follow-up report received from the physician on 01 Nov 2012: Updated reporter information, lab data, medical history, and concomitant medication, suspect product (dosage and stop date). Seriousness, outcome and causality of event eosinophilis 4.3 and diarrhea were updated.

Follow up report received from physician on 23 Jan 2013: The patient demography, concurrent condition, laboratory data of (24 Sep 2012, 09 Oct 2012 and 15 Oct 2012), onset date, seriousness, outcome and causality of the events (bowel infection and eosinophilia) updated.</narrativeincludeclinical>
				<sendercomment>Based on  Review of available reported data does not allow for a proper causality assessment. Reported event gastrointestinal infection is unassessable.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr>
